End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study

被引:4
|
作者
Molaoa, Thabang T. [1 ]
Bisiwe, Feziwe B. [1 ]
Ndlovu, Kwazi C. Z. [2 ,3 ]
机构
[1] Univ Free State, Div Nephrol, Dept Internal Med, Bloemfontein, South Africa
[2] Univ Cape Town, Div Nephrol & Hypertens, Cape Town, South Africa
[3] Univ Cape Town, Kidney & Hypertens Res Unit, Cape Town, South Africa
关键词
Incidence rate; End-stage kidney disease; Kidney replacement therapy; Dialysis access; South Africa; SUB-SAHARAN-AFRICA; RENAL-DISEASE; PERITONEAL-DIALYSIS; HEALTH-CARE; TRANSPLANTATION; PREVENTION; PREVALENCE; OUTCOMES; OLDER; HIV;
D O I
10.1186/s12882-021-02387-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background End-stage kidney disease (ESKD) and the required kidney replacement therapy (KRT) are significant public health challenges for low-and-middle-income countries. The South African government adopted a KRT rationing policy to balance the growing need for KRT and scarce resources. We aimed to describe the epidemiology and KRT access in patients with ESKD referred to the main public sector hospital in the Free State Province, South Africa. Methods A retrospective study of adult patients with ESKD admitted to Universitas Academic Hospital for KRT, was conducted between 1 January 2016 and 31 December 2018. A review of the KRT committee decisions to offer or deny KRT based on the KRT rationing policy of the Free State was undertaken. Demographic information, KRT committee outcomes, laboratory test results, and clinical details were collected from assessment tools, KRT committee meeting diaries, and electronic hospital records. Results Of 363 patients with ESKD referred for KRT access, 96 with incomplete records were excluded and 267 were included in the analysis. Median patient age was 40 (interquartile range, 33-49) years, and male patients accounted for 56.2 % (150/267, p = 0.004) of the cohort. The average annual ESKD incidence was 49.9 (95 % confidence interval [CI], 35.8-64.0) per-million-population. The most prevalent comorbidities were hypertension (42.3 %; 113/267), human immunodeficiency virus (HIV) (28.5 %; 76/267), and diabetes mellitus (19.1 %; 51/267). The KRT access rate was 30.7 % (82/267), with annual KRT incidence rates of 8.05 (95 % CI, 4.98-11.1), 11.5 (95 % CI, 7.83-15.1), and 14.1 (95 % CI, 10.3-18.0) per-million-population in 2016, 2017, and 2018, respectively. Advanced organ dysfunction was the commonest reason recorded for KRT access denial (58.9 %; 109/185). Age (odds ratio [OR], 1.04; 95 % CI, 1.00-1.07; p = 0.024) and diabetes (OR, 5.04; CI, 1.69-15.03; p = 0.004) were independent predictors for exclusion from KRT, while hypertension (OR, 1.80; 1.06-3.04; p = 0.029) independently predicted advanced organ dysfunction resulting in KRT exclusion. Conclusions Non-communicable and communicable diseases, including hypertension, diabetes, and HIV, contributed to ESKD, highlighting the need for improved early prevention strategies to address a growing incidence rate. Two-thirds of ESKD patients were unable to access KRT, with age, diabetes mellitus, and advanced organ dysfunction being significant factors adversely affecting KRT access.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Management of Elderly Patients With End-Stage Kidney Disease
    Dimkovic, Nada
    Oreopoulos, Dimitrios
    SEMINARS IN NEPHROLOGY, 2009, 29 (06) : 643 - 649
  • [32] Ischemic Heart Disease in Patients with End-Stage Kidney Disease
    Tanaka, Yuri
    Joki, Nobuhiko
    Hase, Hiroki
    BLOOD PURIFICATION, 2015, 40 (04) : 332 - 336
  • [33] Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease
    Ramesh, Mayur S.
    Yee, Jerry
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (01) : 30 - 34
  • [34] Lifetime risk of end-stage kidney disease in living donors for paediatric kidney transplant recipients in Australia and New Zealand - a retrospective study
    Lee, Darren
    Whitlam, John B.
    Cook, Natasha
    Walker, Amanda M.
    Roberts, Matthew A.
    Ierino, Francesco L.
    Kausman, Joshua Y.
    TRANSPLANT INTERNATIONAL, 2018, 31 (10) : 1144 - 1152
  • [35] Prolonged respiratory disorder predicts adverse prognosis in infants with end-stage kidney disease
    Sakai, Tomoyuki
    Murakami, Yoshitaka
    Okuda, Yusuke
    Hamada, Riku
    Hamasaki, Yuko
    Ishikura, Kenji
    Hataya, Hiroshi
    Honda, Masataka
    PEDIATRIC NEPHROLOGY, 2016, 31 (11) : 2127 - 2136
  • [36] Academic achievement and employment in young adults with end-stage kidney disease
    Murray, Peter D.
    Brodermann, Maximillian H.
    Gralla, Jane
    Wiseman, Alexander C.
    Harden, Paul N.
    JOURNAL OF RENAL CARE, 2019, 45 (01) : 29 - 40
  • [37] End of life care in end-stage kidney disease
    Prabhu, Ravindra Attur
    Salins, Naveen
    Bharathi
    Abrahams, Georgi
    INDIAN JOURNAL OF PALLIATIVE CARE, 2021, 27 (05) : 37 - 42
  • [38] Urologic care and progression to end-stage kidney disease: a Chronic Kidney Disease in Children (CKiD) nested case-control study
    Chu, D., I
    Abraham, A. G.
    Tasian, G. E.
    Denburg, M. R.
    Ross, M. E.
    Zderic, S. A.
    Furth, S. L.
    JOURNAL OF PEDIATRIC UROLOGY, 2019, 15 (03) : 266.e1 - 266.e7
  • [39] Extracorporeal Techniques in End-Stage Kidney Disease
    Meijers, Bjorn
    Vega, Almudena
    Juillard, Laurent
    Kawanishi, Hideki
    Kirsch, Alexander H.
    Maduell, Francisco
    Massy, Ziad A.
    Mitra, Sandip
    Vanholder, Raymond
    Ronco, Claudio
    Cozzolino, Mario
    BLOOD PURIFICATION, 2023, 53 (05) : 248 - 262
  • [40] Diphenhydramine Use in End-Stage Kidney Disease
    Nguyen, Timothy
    Polyakova, Beatrice
    Cerenzio, John
    Ramilo, Josh Renzo
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (02) : E232 - E237